Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
38 hedge funds and large institutions have $11M invested in Vicarious Surgical in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 21 reducing their positions, and 43 closing their positions.
34.58% more ownership
Funds ownership: 1.34% → 35.92% (+35%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
42% less capital invested
Capital invested by funds: $18.9M → $11M (-$7.91M)
47% less funds holding
Funds holding: 72 → 38 (-34)
71% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 21
79% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$398K |
| 2 |
DP
DDD Partners
Bellevue,
Washington
|
+$155K |
| 3 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$94.3K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$52K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$39.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.07M |
| 2 |
State Street
Boston,
Massachusetts
|
-$356K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$327K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$170K |
| 5 |
DnB Asset Management
Oslo,
Norway
|
-$79.5K |
RBOT Hedge Fund Activity: Q2 2024 in Review
38 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2024, worth a combined $11M — down 42% from $18.9M a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of RBOT and 9 opened new positions — a net loss of 34 holders — while 21 trimmed existing stakes and 6 added.
The largest buyer was Millennium Management, adding an estimated $398K. The largest seller was BlackRock, cutting an estimated $1.07M.
- 38 institutional investors held Vicarious Surgical (RBOT) as of Q2 2024, down from 72 in Q1 2024.
- Funds reported $11M of Vicarious Surgical stock for Q2 2024, down 42% quarter-over-quarter.
- 9 funds opened new Vicarious Surgical positions in Q2 2024 and 43 closed out, a net change of -34 holders.
- The largest Vicarious Surgical buyer in Q2 2024 was Millennium Management, an estimated $398K added.
- The largest Vicarious Surgical seller in Q2 2024 was BlackRock, an estimated $1.07M sold.
Based on aggregated 13F filings for Q2 2024.